JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 32 No. 1 95-101
© 1991 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishiwata, K.
Right arrow Articles by Ido, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishiwata, K.
Right arrow Articles by Ido, T.

Selective 2-[18F]Fluorodopa Uptake for Melanogenesis in Murine Metastatic Melanomas

Kiichi Ishiwata, Kazuo Kubota, Roko Kubota, Ren Iwata, Toshihiro Takahashi and Tatsuo Ido

Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Department of Radiology and Nuclear Medicine, The Research Institute for Tuberculosis and Cancer, Tohoku University, Sendai, Japan

Correspondence: For reprints contact: K. Ishiwata. PhD, Div. Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Aoba Aramaki, Aoba-ku, Sendai 980, Japan.

ABSTRACT

The relationship between 3,4-dihydroxy-2-[18F]fluoro-L-phenylalanine (2-[18F]FDOPA) uptake and melanogenesis was studied using mice bearing two B16 melanomas: B16-F1 has a higher melanin synthesis ability and a slower growing rate than the higher metastatic B16-F10. A significantly higher 2-[18F]FDOPA uptake by B16-F1 than by B16-F10 and a reverse relationship for the uptake of [14C] 2-deoxy-2-fluoro-D-glucose and [3H]thymidine were observed 1 hr postinjection. F1-to-F10 ratios of both the 2-[18F]FDOPA uptake and the acid-insoluble radioactivity increased to about 5 at 6 hr, which paralleled the melanin content. FM3A mammary carcinoma showed a 2-[18F] FDOPA uptake similar to the B16-F10 but without the acid-insoluble radioactivity. With D,L-DOPA loading, a 55% decreased uptake by FM3A 1 hr postinjection was significantly greater than the 20% reduction in both melanomas. O-Methylated 2-[18F]FDOPA was a predominant acid-soluble metabolite in all tumors. Whole-body autoradiography discriminated the two melanomas clearly. 2-[18F]FDOPA may be a promising tracer for the selective imaging of melanogenesis.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Z. Cheng, A. Mahmood, H. Li, A. Davison, and A. G. Jones
[99mTcOAADT]-(CH2)2-NEt2: A Potential Small-Molecule Single-Photon Emission Computed Tomography Probe for Imaging Metastatic Melanoma
Cancer Res., June 15, 2005; 65(12): 4979 - 4986.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Dimitrakopoulou-Strauss, L. G. Strauss, and C. Burger
Quantitative PET Studies in Pretreated Melanoma Patients: A Comparison of 6-[18F]Fluoro-L-Dopa with 18F-FDG and 15O-Water Using Compartment and Noncompartment Analysis
J. Nucl. Med., February 1, 2001; 42(2): 248 - 256.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1991 by the Society of Nuclear Medicine.